Treatment options for malignant pleural effusion vary from observation in asymptomatic patients to pleurectomies or even extrapleural pneumonectomies in severe cases.
📌 3 Maddede Bu Makale
🎯
Amaç & Hipotez:of exudate in the pleural space, accompanied by the detection of cancer cells in pleural fluid or tissue, which is the indicator of the disease in its advance stages, and survival time of these patients ranges between 3 and 12 months.
📊
Temel Bulgular & Veri:of exudate in the pleural space, accompanied by the detection of cancer cells in pleural fluid or tissue, which is the indicator of the disease in its advance stages, and survival time of these patients ranges between 3 and 12 months.
💡
Sonuç & Katkı:Treatment options for malignant pleural effusion vary from observation in asymptomatic patients to pleurectomies or even extrapleural pneumonectomies in severe cases.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri
Özet
of exudate in the pleural space, accompanied by the detection of cancer cells in pleural fluid or tissue, which is the indicator of the disease in its advance stages, and survival time of these patients ranges between 3 and 12 months. Treatment options for malignant pleural effusion vary from observation in asymptomatic patients to pleurectomies or even extrapleural pneumonectomies in severe cases.
Abstract
Malign plevral efüzyon, plevral sıvı veya dokuda kanser hücrelerinin saptanması ile birlikte plevral boşlukta önemli miktarda eksüdat birikmesi olarak tanımlanır. İlerlemiş hastalığın bir göstergesidir ve sağkalım süresi 3 ila 12 ay arasında değişir. Malign plevral efüzyon için tedavi seçenekleri asemptomatik hastalarda gözlemden ağır hastalarda plörektomi ve hatta ekstraplevral pnömonektomiye kadar değişkenlik gösterir.
🔖
Bu Makaleye Atıf Yap
KARADAYI, Ş., ŞAHİN, E. (2021). Surgical treatment in malignant pleural effusion. Türk Göğüs Kalp Damar Cerrahisi Dergisi, Cilt: 29 - Sayı: 4, 577–585. https://ajindex.com/articles/418740
Thomas R, Kalomenidis I, Jett J, Gary Lee YC. Effusion from malignant causes. In: Light RW, Gary Lee YC, editors. Textbook of pleural diseases. New York: Taylor & Francis Group, LLC; 2016. p. 278-94
Hudson JL, Puri V. Malignant pleural effusions. In: LoCicero J, Feins RH, Colson YL, Rocco G, editors. General thoracic surgery. Philadelphia: Wolters Kluwer; 2019. p. 8242-366
Rodrîguez-Panadero F, Borderas Naranjo F, López Mejîas J. Pleural metastatic tumours and effusions. Frequency and pathogenic mechanisms in a post-mortem series. Eur Respir J 1989;2:366-9
Özdemir E. Plevra ve plevral sıvının fizyolojisi. In: Şahin E, Karadayı Ş, Katrancıoğlu Ö, editörler. Her yönüyle plevra ve hastalıkları. Sivas: Cumhuriyet Üniversitesi Yayınları; 2018. s. 35-47
Miserocci G, Beretta E, Grasso GS. Mechanics and fluid dynamics of lung and pleural space. In: LoCicero J, Feins RH, Colson YL, Rocco G, editors. General thoracic surgery. Philadelphia: Wolters Kluwer; 2019. p.7158-223
Pilling JE, Dusmet ME, Ladas G, Goldstraw P. Prognostic factors for survival after surgical palliation of malignant pleural effusion. J Thorac Oncol 2010;5:1544-50
Clive AO, Kahan BC, Hooper CE, Bhatnagar R, Morley AJ, Zahan-Evans N, et al. Predicting survival in malignant pleural effusion: Development and validation of the LENT prognostic score. Thorax 2014;69:1098-104
Kara M, Alzafer S, Okur E, Halezeroglu S. The use of single incision thoracoscopic pleurectomy in the management of malignant pleural effusion. Acta Chir Belg 2013;113:270-4
Çelik B, Demircan S, Bek Y, Başoğlu A. Malign plevral effüzyonda farklı plörodezis yöntemleri ile talk ve oksitetrasiklinin karşılaştırılması. Turkish J Thorac Cardiovasc Surg 2004;12:172-9
Dresler CM, Olak J, Herndon JE 2nd, Richards WG, Scalzetti E, Fleishman SB, et al. Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion. Chest 2005;127:909-15
Fysh ET, Tan SK, Read CA, Lee F, McKenzie K, Olsen N, et al. Pleurodesis outcome in malignant pleural mesothelioma. Thorax 2013;68:594-6
Viallat JR, Rey F, Astoul P, Boutin C. Thoracoscopic talc poudrage pleurodesis for malignant effusions. A review of 360 cases. Chest 1996;110:1387-93
Davies HE, Mishra EK, Kahan BC, Wrightson JM, Stanton AE, Guhan A, et al. Effect of an indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion: The TIME2 randomized